| Malignant Appendix Neoplasm studied in …STUDIED_INderived72 of 72show fewer |
|---|
| → studied in | NCT07060014Phase 1 · recruiting NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07271355Phase 3 · recruiting Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial · condition mapped CURATED_BROADER · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263088NA · recruiting EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283939NA · recruiting Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07795749Phase 2 · recruiting Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658196Phase 1 · recruiting TLR9 Immunotherapy for Peritoneal Carcinomatosis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07753824Phase 2 · not yet recruiting A Phase II Study of Ivonescimab Combined With Intraperitoneal Paclitaxel in Patients With High-Grade Metastatic Appendiceal Adenocarcinoma (AA) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · condition mapped CURATED_BROADER · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847063Phase 1 · recruiting Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902872Phase 1/Phase 2 · completed Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07769346recruiting The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291180NA · recruiting A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207305Phase 1/Phase 2 · recruiting A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma · condition mapped CURATED_BROADER · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05277766Phase 1 · active not recruiting Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693452Phase 2 · recruiting Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Mucinous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06101277NA · recruiting Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07587268recruiting Molecular Profiling for Risk Stratification in Appendiceal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05185947Phase 2 · completed Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05780684NA · recruiting Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Mucinous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05947838NA · recruiting A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929015NA · suspended Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Carcinoma by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194995Phase 1/Phase 2 · active not recruiting JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01815359Phase 2 · active not recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505553Phase 2 · completed Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06715839NA · recruiting Target-specific immunoPET Imaging of Digestive System Carcinoma · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05472948Phase 2 · recruiting Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04157322active not recruiting Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526886NA · completed Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124351Phase 4 · recruiting Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108131Phase 2 · completed Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05734430recruiting Genetics of Appendix Cancer Study · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05623787NA · active not recruiting Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665921Phase 1 · terminated A Study of SGN-STNV in Advanced Solid Tumors · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364788recruiting Molecular Characterisation of Appendiceal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040142Phase 2 · completed HIPEC for Peritoneal Carcinomatosis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06216561Phase 1 · withdrawn Intraperitoneal LSTA1 in CRS-HIPEC · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919758unknown Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05305820NA · unknown Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05083338completed Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy · condition mapped ONTOLOGY_EXACT · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03073694Phase 2 · unknown Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02599116NA · unknown Gastrointestinal Microbiome Study of Appendiceal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02963831Phase 1/Phase 2 · completed A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489422NA · completed Programs To Support You During Chemotherapy · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03287947Phase 2 · terminated LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03604653completed Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05452382completed Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02833753Phase 1 · completed Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158349Phase 1 · terminated Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634448NA · not yet recruiting The Prevalence of Appendiceal Tumours in Periappendicular Abscess · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210298unknown International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Malignant Appendix Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00310076Phase 2 · completed Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458809Phase 1 · completed Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01126346NA · completed Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01580410Phase 2 · completed Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903396Phase 2 · terminated Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834169unknown French National Registry of Rare Peritoneal Surface Malignancies · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Mucinous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654160Phase 1 · completed Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019773Phase 1 · completed Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087191NA · terminated EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006112Phase 2 · unknown Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer · condition mapped ALIAS · 72 trials mapped (34 active) | — | — | Appendix Carcinoma | 1 | Observed | clinicaltrials | graph → |